Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for covid-19

The virus of the Severe Acute Respiratory Syndrome – Coronavirus 2 (SARS-CoV-2) is the cause of a fast propagation disease denominated COVID-19. Its epidemiological behavior is characterized by the appearance of recurrent outbreaks exhibiting a large number of patients that develop multiorgan dysfunction that quickly overwhelms the capacity of hea lth services due to the excessive requirement for hospitalizations in intensive care [1]. An important component in this dysfunction is the cardiac involvement that has been attributed to multiple pathophysiological mechanisms among which is the viral direct injury, hypoxemia, hemodynamic instabilit y, systematic swelling, decrease in the expression of the Angiotensin 2 Converting Enzyme (ACE2) receptor, increase in the production of endogenous catecholamines, and toxicity of some medications prescribed for this disease [2].

Source: Heart and Lung - January 2, 2022 Category: Intensive Care Authors: John Jaime Sprockel D íaz, Juan Manuel Rincon, Manuela Alejandra Rondón López, Marisol Bejarano Zuleta, Nathaly Castellanos, Zulima Santofimio Saavedra, Hellen Cárdenas Rodríguez, Diego Felipe Hernandez Barrera, Jhon Edison Parra, Juan José Diaztagl Source Type: research